To control the opioid crisis, states are developing programs within the health care system to fight opioid use disorder (OUD) by increasing both the access to and quality of available treatment for those afflicted. Read More »
Going to the emergency room can be stressful and scary for patients especially if they are over the age of 50. Read More »
Thousands of Americans suffer from Chronic Obstructive Pulmonary Disease (COPD), but new recommendations from a pair of health organizations may help ease their discomfort. Read More »
A study facilitated by Vizient, Inc. and recently published in the Journal of American Medical Association Internal Medicine yielded new insights about patients with presumed penicillin allergies. Read More »
Telehealth can be a new frontier for pharmacists, according to the incoming president of American Pharmacists Association, the association reported on its website. Read More »
Mylan achieves key milestone to provide U.S. multiple sclerosis patients with more affordable generic version of Biogen's Tecfidera® capsules Read More »
A bill introduced by U.S. Sen. Joni Ernst (R-IA) would give companies incentives if they brought their pharmaceutical, supply and medical device manufacturers back to the United States from China, the Ripon Advance reported. Read More »
Under revised terms, AcelRx to acquire Tetraphase for $37.0 million in stock and cash plus CVRs Read More »
International reference pricing (IRP) for drugs is under consideration in the U.S. as health care experts are discussing an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting to be held annually. Read More »
The newest litigation against a major pharmacy benefit manager (PBM) comes from a likely source: its small business victims. Read More »
Adding Magnesium To Hydroxychloroquine, Azithromycin and Zinc Treatment Protocols May Offset Cardiac Issues(1,3) Read More »
Eurofins Discovery's mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development. Read More »
Vaprisol® safely and effectively addresses hyponatremia in the first 24 hours Read More »
Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials showed inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 months Read More »
The American Pharmacists Association (APhA) submitted comments to the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice. Read More »
.jpg){kind=tracking}
As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx. Read More »
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). Read More »
Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today they are working with UF Health Jacksonville to help advance specialty pharmacy services. Read More »
.jpg){kind=tracking}
e5 Pharma, LLC., today announced the U.S. launch of Diazoxide, USP Oral Suspension, the first generic version of the reference listed drug, Proglycem®. e5 Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) using the Competitive Generic Therapy (CGT) Pathway. Read More »
Nearly 90 percent survival for patients who received REGN-EB3 treatment earlier in the course of their disease; 66.5 percent survival among all patients who received REGN-EB3 Read More »
Alerts Sign-up
